SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q1 2023
Institutional positions in SAB Biotherapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +1 vs. Q4 2022
- Shares held
- 3.87M
- −223.2K (−5.5%) vs. Q4 2022
- Total value
- $1.71M
- −$706.1K (−29.2%) vs. Q4 2022
- New holders
- 7
- 4 more added
- Sold out
- 6
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 881 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 54 | $24 | 0.00% | +54 | New |
| GWM Advisors LLC | 145 | $64 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 187 | $82 | 0.00% | +2+1.1% | Added |
| Harbour Investments, Inc. | 500 | $220 | 0.00% | +500 | New |
| Gs Investments, Inc. | 2,000 | $880 | 0.00% | +2,000 | New |
| Royal Bank of Canada | 4,820 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,679 | $2.94K | 0.00% | −248−3.6% | Reduced |
| Elgethun Capital Management | 7,041 | $3.22K | 0.00% | −7,755−52.4% | Reduced |
| Baird Financial Group, Inc. | 10,000 | $4.40K | 0.00% | 00.0% | Unchanged |
| 1st Source Bank | 10,000 | $4.40K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 11,000 | $4.84K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 13,439 | $5.91K | 0.00% | +13,439 | New |
| Nadler Financial Group, Inc. | 13,750 | $6.05K | 0.00% | 00.0% | Unchanged |
| Strategic Financial Concepts, LLC | 15,027 | $6.61K | 0.00% | +15,027 | New |
| Tower Research Capital LLC (TRC) | 16,062 | $7.00K | 0.00% | +4,651+40.8% | Added |
| Virtu Financial LLC | 15,014 | $7.00K | 0.00% | +15,014 | New |
| Charles Schwab Investment Management Inc | 16,238 | $7.14K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 17,306 | $7.61K | 0.00% | +99+0.6% | Added |
| Advisor Group Holdings, Inc. | 19,096 | $8.40K | 0.00% | 00.0% | Unchanged |
| LGL Partners, LLC | 23,000 | $10.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 28,400 | $12.5K | 0.00% | −80,815−74.0% | Reduced |
| Brookstone Capital Management | 21,755 | $16.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 44,476 | $19.6K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 47,518 | $20.9K | 0.00% | −1,000−2.1% | Reduced |
| Silver Oak Securities, Inc | 51,891 | $23.0K | 0.00% | −50−0.1% | Reduced |
| Mariner, LLC | 69,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 73,470 | $32.0K | 0.00% | −2,500−3.3% | Reduced |
| State Street Corp | 81,241 | $35.7K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 84,000 | $37.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 110,013 | $48.4K | 0.00% | +1,860+1.7% | Added |
| Meteora Capital, LLC | 134,524 | $59.2K | 0.01% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 149,774 | $65.9K | 0.01% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 177,659 | $78.2K | 0.02% | −192,711−52.0% | Reduced |
| First Manhattan Co | 277,777 | $122.2K | 0.00% | +277,777 | New |
| Geode Capital Management, LLC | 300,529 | $132.2K | 0.00% | 00.0% | Unchanged |
| Veritable, L.P. | 506,513 | $222.9K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 701,584 | $308.7K | 0.00% | 00.0% | Unchanged |
| First PREMIER Bank | 807,535 | $355.0K | 0.10% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 0 | $0 | 0.00% | −236,621−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −18,700−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,441−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |